Former Nebraska Sen. Ben Sasse is facing an unimaginable challenge. Diagnosed with Stage 4 pancreatic cancer, Sasse confronts his mortality directly. In a recent New York Times podcast, he shared a perspective filled with hope rather than despair. “Death is a wicked thief, and the bastard pursues us all,” he noted in his candid post, revealing both the gravity of his situation and the strength of his spirit.
At 54 years old, Sasse is a husband and a father who has been given a prognosis that few can bear. The statistics are sobering; with a mere 3.2 percent survival rate for those with his condition, he understands that time is not on his side. Yet, even in the face of this dire diagnosis, Sasse urges others to “orient our hearts toward the hope of what’s to come.”
He does not shy away from the reality of his situation. “Optimism is great, and it’s absolutely necessary, but it’s insufficient,” he stated, emphasizing that confronting harsh truths is vital, especially when grappling with the impact of his illness on his loved ones. His acknowledgment resonates; he candidly expressed sorrow about not being there to walk his daughters down the aisle and the heartbreak it causes parents to think about outliving their children.
As he recounted his diagnosis—a life filled with kindness rapidly altered by illness—Sasse’s sense of humor emerged. His reflections during the interview were marked by a lightness that seemed to contradict the heavy nature of his circumstances. Even as he faces side effects from treatment that leave him physically unwell, he manages to find moments of levity. “When I got the news, I was like, ‘OK, you came in with the real stuff,’” he recalled, indicating a resilience inappropriate to his circumstances.
His medical ordeal began as back pain, which many could consider a minor inconvenience. However, it revealed something far more severe—a misdiagnosis led to the discovery of multiple cancers. Sasse recalled his doctor stating starkly, “Here’s a hard fact: Ben Sasse’s torso is chock-full of tumors.” This brutal reality has forced him to adapt quickly, facing the consequences with a blend of sorrow and acceptance.
A resident of Austin, Texas, Sasse now participates in a targeted clinical trial in Houston. He takes a medication that he described as “nasty,
"*" indicates required fields
